Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Cochran

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
Leukemia Research|October 1, 1992
Role of interleukin 6 in the growth of myeloma-derived cell linesB A Barut, L I Zon, M K Cochran, et al.
Clinical Endocrinology|December 14, 2007
Leptin therapy for partial lipodystrophy linked to a PPAR-gamma mutationJean-Marc Guettier, Jean Y Park, Elaine K Cochran, et al.
Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc|April 4, 2009
Albuterol metered dose inhaler performance under hyperbaric pressuresG A Johnson, V R Gutti, S K Loyalka, et al.
Hepatology (Baltimore, Md.)|March 26, 2005
Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophyEdward D Javor, Marc G Ghany, Elaine K Cochran, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 13, 2009
High-dose insulin therapy: is it time for U-500 insulin?Wendy S Lane, Elaine K Cochran, Jeffrey A Jackson, et al.
Journal of Hepatology|February 27, 2013
The liver diseases of lipodystrophy: the long-term effect of leptin treatmentElika Safar Zadeh, Andreea O Lungu, Elaine K Cochran, et al.
Cancer Research|March 1, 1986
Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patientsJ G Wagner, J W Gyves, P L Stetson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Extended continuous infusion low-dose recombinant interleukin-2 in advanced cancer: prolonged immunomodulation without significant toxicityM A Caligiuri, C Murray, R J Soiffer, et al.
Blood|October 1, 1993
Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantationR J Soiffer, R Gonin, C Murray, et al.
Obesity Science & Practice|March 9, 2019
Visceral fat does not contribute to metabolic disease in lipodystrophyN Malandrino, J C Reynolds, R J Brychta, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Leukemia Research|October 1, 1992
Role of interleukin 6 in the growth of myeloma-derived cell linesB A Barut, L I Zon, M K Cochran, et al.
Clinical Endocrinology|December 14, 2007
Leptin therapy for partial lipodystrophy linked to a PPAR-gamma mutationJean-Marc Guettier, Jean Y Park, Elaine K Cochran, et al.
Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc|April 4, 2009
Albuterol metered dose inhaler performance under hyperbaric pressuresG A Johnson, V R Gutti, S K Loyalka, et al.
Hepatology (Baltimore, Md.)|March 26, 2005
Leptin reverses nonalcoholic steatohepatitis in patients with severe lipodystrophyEdward D Javor, Marc G Ghany, Elaine K Cochran, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 13, 2009
High-dose insulin therapy: is it time for U-500 insulin?Wendy S Lane, Elaine K Cochran, Jeffrey A Jackson, et al.
Journal of Hepatology|February 27, 2013
The liver diseases of lipodystrophy: the long-term effect of leptin treatmentElika Safar Zadeh, Andreea O Lungu, Elaine K Cochran, et al.
Cancer Research|March 1, 1986
Steady-state nonlinear pharmacokinetics of 5-fluorouracil during hepatic arterial and intravenous infusions in cancer patientsJ G Wagner, J W Gyves, P L Stetson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1991
Extended continuous infusion low-dose recombinant interleukin-2 in advanced cancer: prolonged immunomodulation without significant toxicityM A Caligiuri, C Murray, R J Soiffer, et al.
Blood|October 1, 1993
Prediction of graft-versus-host disease by phenotypic analysis of early immune reconstitution after CD6-depleted allogeneic bone marrow transplantationR J Soiffer, R Gonin, C Murray, et al.
Obesity Science & Practice|March 9, 2019
Visceral fat does not contribute to metabolic disease in lipodystrophyN Malandrino, J C Reynolds, R J Brychta, et al.
Pageof 10